 NEW YORK, Dec. 10, 2020 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of scPharmaceuticals Inc. scPharmaceuticals or the Company NASDAQ: SCPH. uch investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext... 